3 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Microbubble driven multimodal imaging and theranostics for gliomas (THERAGLIO)
Date du début: 1 oct. 2013, Date de fin: 30 sept. 2018,
Microbubbles (MBs) are used as contrast agent in ultrasound (US) imaging for a variety of tumours while little has been done for glioblastomas, a rare cancer. Intraoperative Contrast-Enhanced US-imaging (CEUS) using lipidic MBs hold promises in increasing extent of resection of such tumors. Furthermore, MBs gained recently interest as a delivery system for drugs. We will develop a new generation o ...
Voir le projet
12
Participants partenaires
TERMINÉ
New Oral Nanomedicines: Transporting Therapeutic Macromolecules across the Intestinal Barrier (TRANS-INT)
Date du début: 1 mai 2012, Date de fin: 30 avr. 2017,
Despite the increasing number of macromolecules with potential impact in the treatment of devastating systemic diseases, these therapies have failed to deliver on their expectations because they cannot be administered in the fashion which is most cost efficient and has the highest patient compliance: the oral route. The availability of an oral form of administration could lead to a great improveme ...
Voir le projet
20
Participants partenaires
TERMINÉ
Monoclonal ANTIbody-targeted CARBon nanobues against cancer (ANTICARB)
Date du début: 1 mars 2008, Date de fin: 31 août 2011,
"ANTICARB attempts to exploit the advantages offered by a novel nanotechnology platform – carbon nanotubes – and apply them to a clinically established therapeutic modality – targeted antibody therapy – for the creation of hybrid nanotechnology-based monoclonal antibody targeted cancer therapeutics. ANTICARB combines two emerging technologies, antibody and nanotube technology, in a way that will a ...
Voir le projet